Plus Therapeutics Reports Second Quarter 2020 Financial and Business Results

NEXT STORY
Enlivex Announces Dosing of First Patient in Clinical Trial of Allocetra in COVID-19 Patients with Severe Illness Respiratory Failure
PREV STORY
Revolution Medicines Reports Second Quarter 2020 Financial Results and Provides Update on Corporate Progress
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Aktana Delivers Intelligent Engagement Solution to Emerging and Mid-sized Life Sciences Companies

author_avatar
NASDAQ Market News

Novan to Present Clinical Data at Annual Meeting of the Society for Investigative Dermatology

author_avatar
NASDAQ Market News

PAVmed Subsidiary Lucid Diagnostics Partners with Fred Hutchinson Cancer Research Center to Evaluate Barrett’s Esophagus (BE) Progression Biomarkers Using EsoCheck™

author_avatar
NASDAQ Market News